No Evidence to Support Delay in Excision of Malignant Melanoma

Coldiron, Brett M.

doi:10.1001/archderm.136.10.1269-a

Cited by 6 publications

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Even if no disruptions were made by initial WLE, consideration should be given to the patient so that WLE can be done simultaneously with SSL [47,48]. A delayed SSL may be performed for patients who have had WLE if the primary melanoma is in the extremities [49].…”

Section: Cost Effectivenessmentioning

confidence: 99%

Sentinel lymph node mapping and selective lymphadenectomy: The standard of care for melanoma

Leong

2004

Curr. Treat. Options in Oncol.

View full text Add to dashboard Cite

Selective sentinel lymphadenectomy (SSL) should be considered a standard of care approach for staging patients with primary invasive melanoma 1 mm or greater. It is essential that multidisciplinary teams should master the techniques of preoperative lymphoscintigraphy, intraoperative lymphatic mapping, and pathologic evaluation of the sentinel lymph nodes (SLNs). An SLN may be blue, hot, or any lymph node (LN) greater than 10% of the in-vivo count of the hottest LN. An enlarged or indurated LN should be removed because it may contain metastatic cancer cells that block blue dye or radiotracer entry. Frozen sections are not recommended. Surgeons who use isosulfan blue dye should be cognizant of treatment for a potentially fatal reaction. Prophylactic LN dissection should not be performed if a SSL can be performed as a staging procedure. A complete LN dissection is performed if the SLN is positive. It is important to follow the clinical outcome of patients undergoing SSL, thus its role can be further defined.

show abstract

Section: Cost Effectivenessmentioning

confidence: 99%

Sentinel lymph node mapping and selective lymphadenectomy: The standard of care for melanoma

Leong

2004

Curr. Treat. Options in Oncol.

View full text Add to dashboard Cite

show abstract

“… 8 – 10 Early diagnosis and treatment are considered paramount for melanoma, and delayed treatment is hypothesized to affect survival. 6 , 11 In the 1980's, a Scottish study revealed a surprisingly high proportion of patients presenting with melanomas categorized as thick, poor prognosis and only 16% of patients underwent surgical treatment within three months of noticing the pigmented lesion. In response, a public education campaign began to promote early detection.…”

Section: Introductionmentioning

confidence: 99%

Defining an acceptable period of time from melanoma biopsy to excision

Huff

Chang²,

Thomas³

et al. 2012

Dermatol Reports

View full text Add to dashboard Cite

Melanoma is the most lethal form of skin cancer and it is the second most common cancer among adolescents and young adults. The aim of this work is to determine if surgical intervals differ between four different clinics and between departments within the hospitals, and to compare these to industry standards. Surgical intervals were measured through retrospective chart review at four dermatology clinics. Of 205 melanoma cases, clinic and departmental median surgical intervals ranged 15–36.5 days and 26–48 days, respectively. There was significant association between clinic and time between biopsy and pathology report, time between pathology report and excision, and total surgical interval (P<0.0001, P=0.03, and P<0.0001 respectively). There was significant association between department and time between pathology report and excision, and surgical interval (P<0.0001, and P=0.003 respectively). Pair-wise comparisons detected significantly longer intervals between some clinics and departments (maximum difference 67.3%, P<0.0001). Hypothesis-based, informal guidelines recommend treatment within 4–6 weeks. In this study, median surgical intervals varied significantly between clinics and departments, but nearly all were within a 6-week frame.

show abstract

Selective Sentinel Lymph Node Mapping and Dissection for Malignant Melanoma

Leong

Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer

View full text Add to dashboard Cite

No Evidence to Support Delay in Excision of Malignant Melanoma

Cited by 6 publications

References 1 publication

Sentinel lymph node mapping and selective lymphadenectomy: The standard of care for melanoma

Sentinel lymph node mapping and selective lymphadenectomy: The standard of care for melanoma

Defining an acceptable period of time from melanoma biopsy to excision

Selective Sentinel Lymph Node Mapping and Dissection for Malignant Melanoma

Contact Info

Product

Resources

About